Corporate Information

• Mission and People
  • Management Team
  • Board of Directors
  • Scientific Advisory Board
  • Employment
• Location
  • Facilities
• Business Development
  • IP Licensing
  • Consulting
  • Contract Services
  • Grant Collaboration

Fluorous Technologies Board of Directors

Mr. H. Lee Noble

Founder and CEO, Noble Consulting

Mr. Noble recently retired from a 25 year career at Bayer Corp. For the last 8 years he served as President of that company's Polymer Division and Executive Vice President of the Corporation. During his tenure, the Division more than doubled sales to over $2 billion, completed 4 major acquisitions and completed a capital project of over $1.2 billion. For the past four years, he also served as Chairman of the Board of Deerfield Urethanes, a subsidiary of Bayer. Mr. Noble is currently CEO of Noble Consulting, specializing in Strategic Planning, Mergers and Acquisitions and Financing of Start-up Companies.

During the last 10 years, Mr. Noble has actively participated in a number of industry, civic, and charitable groups. He served as a member of the Board of Directors and the Executive Committee of the Society of the Plastics Industry, Chairman of the Board of Directors of the International Isocyanate Institute and member of the founding committee of the American Plastics Council and its Board of Directors. He continues to be an active member of the Board of Directors and Executive Committee of Lifeswork of Western Pa (formerly the VRC), where he previously served two terms as Chairman of the Board. He was a founder of Pittsburgh Project for Employment of Persons with Disabilities (Project Freedom) and continues on their Board of Directors. He is a member of the Board of Directors of the University of Pittsburgh, the University of Pittsburgh Medical System (UPMC), Pittsburgh Chamber of Commerce and Pittsburgh Regional Alliance.

Dr. Harold Meckler

Vice President of Science and Technology, AMRI

Since 2000, Dr. Meckler has led AMRI's Science & Technology department. This group helps to manage the AMRI IP portfolio, internal research projects, Scientific Information systems and the AMRI sample collection. Dr. Meckler joined AMRI in 1995 to head up the Chemical Development and cGMP Production Groups. Prior to that he worked at Telor Ophthalmic Pharmaceuticals (Wilmington, Massachusetts) and built their Organic Chemistry Department. In 1984, Dr. Meckler joined the Chemical Development Group of the CIBA Pharmaceuticals Division (Summit, New Jersey) where he focused on the process development, pilot plant scale up and cGMP production of a wide variety of compounds. Prior to that, Dr. Meckler worked in the Chemical Development Group of Sterling Winthrop (Rensselaer, New York). Dr. Meckler earned his Ph.D. in 1983 from the State University of New York at Buffalo. He is a member of the Editorial Advisory Board of Organic Process Research and Development.

Dr. Philip E. Yeske

President and CEO, Fluorous Technologies

Dr. Philip E. Yeske received a B.S. in Chemistry from Allegheny College in 1985 and a doctorate from Emory University in 1990 under the direction of Professor Albert Padwa. After working with Professor Dennis Curran at the University of Pittsburgh as a Postdoctoral Fellow, Dr. Yeske joined Bayer Corporation in 1991. There he held positions progressing from basic research to global account management over a 10-year period within the Coatings Raw Materials Business Group. He also completed a 4-year marketing assignment at Bayer's corporate headquarters in Leverkusen, Germany. Dr. Yeske has co-authored over 20 U.S. patents and was a co-winner of the prestigious "Otto Bayer Medallion" at Bayer in 1995.

Mr. Daniel J. Bader

President and CEO, Helen Bader Foundation

Mr. Bader is President and CEO of the Milwaukee-based Helen Bader Foundation, which supports worthy organizations working in key areas affecting the quality of life in Wisconsin, Milwaukee, and Israel. The Foundation has awarded more then $150 million in grants since it was established in 1992. In addition, Mr. Bader serves as Chairman of the Board of Granite Microsystems, Inc., a manufacturer of custom-integrated computers and computer-related products, and Generation Growth Capital, which operates a private equity fund that invests in growth companies located in low income communities in Milwaukee and throughout Wisconsin. He also holds positions on the Boards of the Greater Milwaukee Committee, Rochester Institute of Technology, Queen's University in Kingston, Ontario, and is actively involved in several civic service organizations.

Mr. Joseph M. Bernstein

Mr. Bernstein is a graduate of the Wharton School of Finance and the University of Wisconsin Law School. He is a member of the law firm of Godfrey & Kahn, S.C., which has offices throughout Wisconsin as well as in Washington, D.C., and Shanghai, China. Mr. Bernstein is actively involved in private equity capital investment and has made over one hundred private equity investments. He is the past Chairman of the Blood Research Institute of Wisconsin which conducts discovery research with an annual budget of $20 million. He is a member of the Executive Committee of the Board of Materia, Inc., a catalyst firm whose organizers received the Nobel Prize for Chemistry in 2005 for technology owned by Materia. Also, he is a member of the Management Committee of Tactics II, a private equity fund that is a founding investor in Cellular Dynamics International, along with Dr. James Thompson and his colleagues from the University of Wisconsin. Cellular Dynamics was organized to commercialize stem cell technology discovered and developed in Dr. Thompson's laboratories.